From February 7, 2024 to March 31, 2024, the company has repurchased 8,332,700 shares, representing 4.13% for CNY 275 million. With this, the company has completed the repurchase of 8,332,700 shares, representing 4.13% for CNY 275 million under the buyback announced on February 8, 2024.
Zhejiang Orient Gene Biotech Co.,Ltd
Equities
688298
CNE100003RM8
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.52 CNY | +1.67% |
|
+2.08% | -28.64% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.64% | 697M | |
-6.61% | 12.07B | |
+96.15% | 8.2B | |
-18.38% | 6.59B | |
+9.13% | 5.89B | |
-21.66% | 3.47B | |
+5.36% | 2.52B | |
+41.54% | 2.48B | |
+17.72% | 2.3B | |
-18.43% | 1.58B |
- Stock Market
- Equities
- 688298 Stock
- News Zhejiang Orient Gene Biotech Co.,Ltd
- Tranche Update on Zhejiang Orient Gene Biotech Co.,Ltd's Equity Buyback Plan announced on February 8, 2024.